Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

STERIS plc

NYSE

Market Cap.

22.99B

Avg. Volume

510.94K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze STERIS plc!

Still processing it, give me a bit more time...

STERIS plc News

STERIS plc Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
steris.com

About STERIS plc

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STERIS plc Earnings & Revenue

STERIS plc Financials

Table Compare

Compare STE metrics with:

   

Earnings & Growth

STE

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

STE

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

STE

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

STE

None

Debt Ratio

--

--

Quick Ratio

--

--

 

STERIS plc Income

STERIS plc Balance Sheet

STERIS plc Cash Flow

STERIS plc Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsNeutral
Debt/Equity RatioBuy
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

STERIS plc Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.08

Payment DateDividendFrequency
2024-06-260.52Quarterly
2024-03-220.52Quarterly
2023-12-210.52Quarterly
2023-09-220.52Quarterly
2023-06-280.47Quarterly

Historical Market Cap

Shares Outstanding

STERIS plc Executives

NameRole
Mr. Daniel A. CarestioPresident, Chief Executive Officer & Director
Mr. Andrew XilasSenior Vice President & GM of Dental
Mr. Michael J. TokichSenior Vice President & Chief Financial Officer
Mr. John Adam ZangerleSenior Vice President, General Counsel & Secretary
Mr. Cary L. MajorsSenior Vice President & President of Healthcare
NameRoleGenderDate of BirthPay
Mr. Daniel A. CarestioPresident, Chief Executive Officer & DirectorMale19731.59M
Mr. Andrew XilasSenior Vice President & GM of DentalMale19651.44M
Mr. Michael J. TokichSenior Vice President & Chief Financial OfficerMale1969838.61K
Mr. John Adam ZangerleSenior Vice President, General Counsel & SecretaryMale1967718.45K
Mr. Cary L. MajorsSenior Vice President & President of HealthcareMale1975615.61K

STERIS plc Insider Trades

Date15 May
NameFELDMANN CYNTHIA L
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares2000
Date15 May
NameFELDMANN CYNTHIA L
RoleDirector
TransactionDisposed
TypeS-Sale
Shares2000
Date15 May
NameFELDMANN CYNTHIA L
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares2000
Date15 May
NameTOKICH MICHAEL J
RoleSr. Vice Pres., CFO
TransactionAcquired
TypeM-Exempt
Shares32000
Date15 May
NameTOKICH MICHAEL J
RoleSr. Vice Pres., CFO
TransactionDisposed
TypeS-Sale
Shares5039
DateNameRoleTransactionTypeShares
15 MayFELDMANN CYNTHIA LDirectorAcquiredM-Exempt2000
15 MayFELDMANN CYNTHIA LDirectorDisposedS-Sale2000
15 MayFELDMANN CYNTHIA LDirectorDisposedM-Exempt2000
15 MayTOKICH MICHAEL JSr. Vice Pres., CFOAcquiredM-Exempt32000
15 MayTOKICH MICHAEL JSr. Vice Pres., CFODisposedS-Sale5039

Discover More

Streamlined Academy

STERIS plc

NYSE

Market Cap.

22.99B

Avg. Volume

510.94K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

STERIS plc News

STERIS plc Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

STERIS plc Earnings & Revenue

STERIS plc Income

STERIS plc Balance Sheet

STERIS plc Cash Flow

STERIS plc Financials Over Time

STERIS plc Executives

NameRole
Mr. Daniel A. CarestioPresident, Chief Executive Officer & Director
Mr. Andrew XilasSenior Vice President & GM of Dental
Mr. Michael J. TokichSenior Vice President & Chief Financial Officer
Mr. John Adam ZangerleSenior Vice President, General Counsel & Secretary
Mr. Cary L. MajorsSenior Vice President & President of Healthcare
NameRoleGenderDate of BirthPay
Mr. Daniel A. CarestioPresident, Chief Executive Officer & DirectorMale19731.59M
Mr. Andrew XilasSenior Vice President & GM of DentalMale19651.44M
Mr. Michael J. TokichSenior Vice President & Chief Financial OfficerMale1969838.61K
Mr. John Adam ZangerleSenior Vice President, General Counsel & SecretaryMale1967718.45K
Mr. Cary L. MajorsSenior Vice President & President of HealthcareMale1975615.61K

STERIS plc Insider Trades

Date15 May
NameFELDMANN CYNTHIA L
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares2000
Date15 May
NameFELDMANN CYNTHIA L
RoleDirector
TransactionDisposed
TypeS-Sale
Shares2000
Date15 May
NameFELDMANN CYNTHIA L
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares2000
Date15 May
NameTOKICH MICHAEL J
RoleSr. Vice Pres., CFO
TransactionAcquired
TypeM-Exempt
Shares32000
Date15 May
NameTOKICH MICHAEL J
RoleSr. Vice Pres., CFO
TransactionDisposed
TypeS-Sale
Shares5039
DateNameRoleTransactionTypeShares
15 MayFELDMANN CYNTHIA LDirectorAcquiredM-Exempt2000
15 MayFELDMANN CYNTHIA LDirectorDisposedS-Sale2000
15 MayFELDMANN CYNTHIA LDirectorDisposedM-Exempt2000
15 MayTOKICH MICHAEL JSr. Vice Pres., CFOAcquiredM-Exempt32000
15 MayTOKICH MICHAEL JSr. Vice Pres., CFODisposedS-Sale5039

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
steris.com

About STERIS plc

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze STERIS plc!

Still processing it, give me a bit more time...

STERIS plc Financials

Table Compare

Compare STE metrics with:

   

Earnings & Growth

STE

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

STE

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

STE

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

STE

None

Debt Ratio

--

--

Quick Ratio

--

--

 

STERIS plc Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

2.08

Payment DateDividendFrequency
2024-06-260.52Quarterly
2024-03-220.52Quarterly
2023-12-210.52Quarterly
2023-09-220.52Quarterly
2023-06-280.47Quarterly

STERIS plc Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsNeutral
Debt/Equity RatioBuy
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More